Volume 21, Number 8—August 2015
Synopsis
Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France
Table 2
Bacterial species |
Resistance phenotypes |
β-lactam antibiotics |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AMX |
TIC |
AMC |
TCC |
TZP |
FOX |
OXA |
CRO |
FEP |
CAZ |
IPM |
||
Escherichia coli | ||||||||||||
Wild-type | S | S | S | S | S | S | S | |||||
Low-level penicillinase | I/R | I/R | S | S | S | S | S | |||||
Inhibitor-resistant penicillinase | I/R | I/R | R | R | S | S | S | |||||
High-level penicillinase | I/R | I/R | I/R | I/R | S | S | S | |||||
ESBL | R | R | S/I/R | S/I/R | I/R | I/R | S | |||||
High-level cephalosporinase |
R |
R |
R |
R |
R |
S |
S |
|||||
Klebsiella pneumoniae | Wild-type | S | S | S | S | S | ||||||
ESBL | I/R | I/R | I/R | I/R | S | |||||||
High-level cephalosporinase | I/R | I/R | I/R | S | S | |||||||
ESBL-TZP-sensible |
I/R |
S |
I/R |
I/R |
S |
|||||||
Proteus mirabilis |
Wild | S | S | S | S | S | S | S | ||||
Low-level penicillinase | I/R | I/R | S | S | S | S | S | |||||
Inhibitor-resistant penicillinase | R | R | R | R | S | S | S | |||||
High-level penicillinase | R | R | I/R | I/R | S | S | S | |||||
ESBL | R | R | I/R | I/R | I/R | I/R | S | |||||
High-level cephalosporinase |
R |
R |
R |
R |
R |
S |
S |
|||||
Klebsiella oxytoca |
Wild-type | S | S | S | S | |||||||
ESBL | I/R | I/R | I/R | S | ||||||||
High-level penicillinase | I/R | S/I/R | S | S | ||||||||
Low-level penicillinase | S | R | S | S | ||||||||
ESBL–TZP-sensible |
I/R |
S |
I/R |
S |
||||||||
Enterobacter aerogenes |
Wild-type | S | S | S | S | S | ||||||
Inhibitors-resistant penicillinase | R | R | S | S | S | |||||||
ESBL | S/I/R | I/R | I/R | I/R | S | |||||||
High-level cephalosporinase |
I/R |
I/R |
I/R |
S |
S |
|||||||
Morganella morganii |
Wild-type | S | S | S | S | S | ||||||
Inhibitor-resistant penicillinase | R | R | S | S | S | |||||||
ESBL | S/I/R | I/R | I/R | I/R | S | |||||||
High-level cephalosporinase |
I/R |
I/R |
I/R |
S |
S |
|||||||
Serratia marcescens |
Wild-type | S | S | S | S | S | ||||||
Inhibitor-resistant penicillinase | R | R | S | S | S | |||||||
ESBL | S/I/R | I/R | I/R | I/R | S | |||||||
High-level cephalosporinase |
I/R |
I/R |
I/R |
S |
S |
|||||||
Enterobacter cloacae |
Wild-type | S | S | S | S | S | ||||||
Inhibitor-resistant penicillinase | R | R | S | S | S | |||||||
ESBL | S/I/R | I/R | I/R | I/R | S | |||||||
High-level cephalosporinase |
I/R |
I/R |
I/R |
S |
S |
|||||||
Pseudomonas aeruginosa |
Wild-type | S | S | S | S | S | S | |||||
Penicillinase | R | R/I/S | I/S | S | S | S | ||||||
High-level penicillinase | I/R | I/R | I/R | S | S | S | ||||||
ESBL | I/R | I/R | I/R | I/R | I/R | S | ||||||
Selective permeability to imipenem | S | S | S | S | S | R | ||||||
Penicillinase, loss of D2 porine |
R |
R |
S |
S |
S |
R |
||||||
Acinetobacter baumannii |
Wild-type | S | S | S | S | |||||||
Penicillinase | R | R/I/S | S | S | ||||||||
ESBL |
I/R |
I/R |
I/R |
S |
||||||||
Streptococcus agalactiae |
Wild | S | S | |||||||||
Oxacillin-resistant |
I/R |
S |
||||||||||
Enterococcus faecalis |
Wild-type |
S |
||||||||||
E. faecium |
Wild-type |
I/R |
||||||||||
Staphylococcus aureus |
Wild-type | S | ||||||||||
Methicillin-resistant |
I/R |
|||||||||||
S. epidermidis | Wild-type | S | ||||||||||
Methicillin-resistant | I/R |
*MARSS, Marseille Antibiotic Resistance Surveillance System; AMC, amoxicillin; TIC, ticarcillin; AMC, amoxicillin/clavulanic acid; TIC, ticarcillin/clavulanic acid; TZP, piperacillin/tazobactam; FOX, cefoxitin; OXA, oxacillin; CRO, ceftriaxone; FEP, cefepime; CAZ, ceftazidime; IMP, imipenem; S, susceptible; I, intermediate; R, resistant; ESBL, extended-spectrum β-lactamase.
Page created: July 14, 2015
Page updated: July 14, 2015
Page reviewed: July 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.